Cite
Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.
MLA
Zhu, Yuanjie, et al. “Association of Serum 25-Hydroxyvitamin D3, Fibroblast Growth Factor-23, and C1q/Tumor Necrosis Factor-Related Protein-3 with Coronary Artery Calcification in Nondialysis Chronic Kidney Disease Patients.” Renal Failure, vol. 45, no. 1, Dec. 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1080/0886022X.2023.2220412.
APA
Zhu, Y., Hu, Z., Liu, Y., Qin, C., Chen, X., Shi, Y., & Wang, L. (2023). Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients. Renal Failure, 45(1), 1–8. https://doi.org/10.1080/0886022X.2023.2220412
Chicago
Zhu, Yuanjie, Zhijuan Hu, Yu Liu, Congcong Qin, Xing Chen, Yanan Shi, and Lijun Wang. 2023. “Association of Serum 25-Hydroxyvitamin D3, Fibroblast Growth Factor-23, and C1q/Tumor Necrosis Factor-Related Protein-3 with Coronary Artery Calcification in Nondialysis Chronic Kidney Disease Patients.” Renal Failure 45 (1): 1–8. doi:10.1080/0886022X.2023.2220412.